1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Viral Antigens Market - By Component
1.3.2 Global Viral Antigens Market - By Technique
1.3.3 Global Viral Antigens Market - By End User
1.3.4 Global Viral Antigens Market - By Geography
2. Viral Antigens Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Viral Antigens Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America- PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion
5. Viral Antigens Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increased Acceptance of Viral Antigens in Vaccine Development
5.1.2 Advancements in Image Analysis Software and Informatics Platforms for Viral Antigen Detection
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Growing Trend of Plant-Made Vaccine Antigens and Biopharmaceuticals
5.5 Impact Analysis
6. Viral Antigens Market - Global Analysis
6.1 Global Viral Antigens Market Revenue Forecast And Analysis
6.2 Global Viral Antigens Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Viral Antigens Market- By Component
7.1 Overview
7.2 Viral Antigens Market Share, by Component, 2019 and 2027 (%)
7.3 Influenza Viral Antigens
7.3.1 Overview
7.3.2 Influenza Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.4 Coronavirus Antigens
7.4.1 Overview
7.4.2 Coronavirus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.5 Zika Virus Antigens
7.5.1 Overview
7.5.2 Zika Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.6 Ebola Virus Antigens
7.6.1 Overview
7.6.2 Ebola Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.7 Dengue Virus Antigens
7.7.1 Overview
7.7.2 Dengue Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.8 Herpes Simplex Virus (HSV) Viral Antigens
7.8.1 Overview
7.8.2 Herpes Simplex Virus (HSV) Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.9 Rotavirus Viral Antigens
7.9.1 Overview
7.9.2 Rotavirus Viral Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.10 Hepatitis A-E Virus Antigens
7.10.1 Overview
7.10.2 Hepatitis A-E Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.11 Measles Virus Antigens
7.11.1 Overview
7.11.2 Measles Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.12 Mumps/Parotitis Virus Antigens
7.12.1 Overview
7.12.2 Mumps/Parotitis Virus Antigens: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
7.13 Others
7.13.1 Overview
7.13.2 Others: Viral Antigens Market- Revenue and Forecast to 2027 (USD Million)
8. Viral Antigens Market Analysis - By Technique
8.1 Overview
8.2 Viral Antigens Market Revenue Share, by Technique (2019 and 2027)
8.3 ELISA
8.3.1 Overview
8.3.2 ELISA: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Immunoassay
8.4.1 Overview
8.4.2 Immunoassay: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Hemagglutination
8.5.1 Overview
8.5.2 Hemagglutination: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Radioimmunoassay (RIA)
8.6.1 Overview
8.6.2 Radioimmunoassay: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Immunoperoxidase Staining
8.7.1 Overview
8.7.2 Immunoperoxidase Staining: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.8 Immunofluorescence
8.8.1 Overview
8.8.2 Immunofluorescence: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9. Viral Antigens Market Analysis - By End User
9.1 Overview
9.2 Viral Antigens Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Laboratories
9.5.1 Overview
9.5.2 Laboratories: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Diagnostic Centres
9.6.1 Overview
9.6.2 Diagnostic Centres: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Blood Banks
9.7.1 Overview
9.7.2 Blood Banks: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Research Institutes
9.8.1 Overview
9.8.2 Research Institutes: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
10. Viral Antigens Market - Geographic Analysis
10.1 North America: Viral Antigens Market
10.1.1 Overview
10.1.2 North America: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.1.4 North America: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.1.5 North America: Viral Antigens Market, by End User, 2018-2027 (USD Million)
10.1.6 North America: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.1.7 US: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.1.7.3 US: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.1.7.4 US: Viral Antigens Market, by End User, 2018-2027 (USD Million)
10.1.8 Canada: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.1.8.3 Canada: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.1.8.4 Canada: viral antigens market, by End User, 2018-2027 (USD million)
10.1.9 Mexico: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.1.9.3 Mexico: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.1.9.4 Mexico: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.2 Europe: Viral Antigens Market
10.2.1 Overview
10.2.2 Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.2.4 Europe: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.2.5 Europe: Viral Antigens Market, by End User, 2018-2027 (USD Million)
10.2.6 Germany: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.6.1 Germany: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.6.2 Germany: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.2.6.3 Germany: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.2.6.4 Germany: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.2.7 UK: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.1 UK Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.7.2 UK: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.2.7.3 UK: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.2.7.4 UK: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.2.8 France: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.1 France: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.2 France: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.2.8.3 France: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.2.8.4 France: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.2.8.5 Spain: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.8.6 Spain: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.2.8.7 Spain: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.2.8.8 Spain: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.2.9 Italy: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.1 Italy: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.9.2 Italy: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.2.9.3 Italy: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.2.9.4 Italy: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.2.10 Rest of Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Rest of Europe: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Rest of Europe: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.2.10.3 Rest of Europe: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.2.10.4 Rest of Europe: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.3 Asia Pacific: Viral Antigens Market
10.3.1 Overview
10.3.2 Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.3 Asia Pacific: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.3.4 Asia Pacific: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.3.5 Asia Pacific: Viral Antigens Market, by End User, 2018-2027 (USD Million)
10.3.6 Asia Pacific: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.3.7 China: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.1 China: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.7.2 China: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.3.7.3 China: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.3.7.4 China: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.3.8 Japan: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.1 Japan: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.8.2 Japan: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.3.8.3 Japan: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.3.8.4 Japan: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.3.9 India: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.1 India: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.9.2 India: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.3.9.3 India: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.3.9.4 India: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.3.10 South Korea: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.1 South Korea: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.2 South Korea: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.3.10.3 South Korea: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.3.10.4 South Korea: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.3.10.5 Australia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.6 Australia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.10.7 Australia: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.3.10.8 Australia: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.3.10.9 Australia: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.3.11 Rest of Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Rest of Asia Pacific: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Rest of Asia Pacific: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.3.11.3 Rest of Asia Pacific: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.3.11.4 Rest of Asia Pacific: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.4 Middle East & Africa: Viral Antigens Market
10.4.1 Overview
10.4.2 Middle East & Africa: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.4.4 Middle East & Africa: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.4.5 Middle East & Africa: Viral Antigens Market, by End User, 2018-2027 (USD Million)
10.4.6 Middle East & Africa: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.4.7.3 Saudi Arabia: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.4.7.4 Saudi Arabia: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.4.8 UAE: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.4.8.3 UAE: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.4.8.4 UAE: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.4.9 South Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.4.9.3 South Africa: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.4.9.4 South Africa: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.4.10 Rest of Middle East and Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.4.10.4 Rest of Middle East and Africa: Viral Antigens Market, by End User, 2018-2027 (USD million)
10.5 South and Central America: Viral Antigens Market
10.5.1 Overview
10.5.2 South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.5.3 South and Central America: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.5.4 South and Central America: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.5.5 South and Central America: Viral Antigens Market, by End User, 2018-2027 (USD Million)
10.5.6 South and Central America: Viral Antigens Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.5.8 Brazil: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.5.9 Brazil: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.5.10 Brazil: Viral Antigens Market, by End User, 2018-2027 (USD Million)
10.5.11 Argentina: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.5.11.1 Argentina: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.5.12 Argentina: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.5.13 Argentina: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.5.14 Argentina: Viral Antigens Market, by End User, 2018-2027 (USD Million)
10.5.15 Rest of Central and South America: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.5.15.1 Rest of Central and South America: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
10.5.16 Rest of Central and South America: Viral Antigens Market, by Component, 2018-2027 (USD Million)
10.5.17 Rest of Central and South America: Viral Antigens Market, by Technique, 2018-2027 (USD Million)
10.5.18 Rest of Central and South America: Viral Antigens Market, by End User, 2018-2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Viral Antigens Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe (EU): Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Viral Antigens Market- Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Microbix Biosystems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BIO-RAD LABORATORIES INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Creative Diagnostics
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Aalto Bio Reagents Ltd.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Advanced Biotechnologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Prospec-Tany Technogene Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ACROBiosystems.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERIDIAN BIOSCIENCE, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Rekom Biotech S.L
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 LGC Limited.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About
14.2 Glossary of Terms